Kimchi N A, Mindrul V, Broide E, Scapa E
Institute of Gastroenterology, Liver Diseases and Nutrition, Assaf-Harofeh Medical Center, Zerifin and the Sackler School of Medicine, Tel-Aviv University, Israel.
Endoscopy. 1998 Aug;30(6):538-43. doi: 10.1055/s-2007-1001340.
Endoscopy and biopsy from a suspicious Vater's papilla may establish an early preoperative diagnosis of a periampullary tumor. However, information regarding the diagnostic accuracy of this procedure is limited and variable. The aim of the present study was to evaluate retrospectively the accuracy of this procedure compared to that of other diagnostic methods.
Among 928 patients referred to our institute for endoscopic retrograde cholangiopancreatography (ERCP), a suspicious Vater's papilla was seen in 28. In each case comparison was made between the pre-ERCP clinical diagnosis, endoscopic appearance, histologic interpretation of endoscopic biopsies, and the final diagnosis. Two patients in whom a final diagnosis was not available were excluded from the study.
A final diagnosis of an ampullary or periampullary carcinoma was established in 17 patients (65%), a carcinoma within an adenoma of the papilla in three patients (12%), and adenoma and a metastatic gallbladder carcinoma in one patient each. The remaining four patients (15%) were finally diagnosed as having "pseudotumors" (due to choledocholithiasis). Eight (38%) of the 21 patients with ampullary or periampullary neoplasm also had gallstones. A pre-ERCP diagnosis (by clinical evaluation and non-invasive imaging) of tumor versus choledocholithiasis was accurate in only 65% of all 26 patients. In these, the diagnostic accuracy of endoscopic appearance and endoscopic biopsy was 77% and 85%, respectively. Regarding the 21 patients with carcinomas, the diagnosis by endoscopic appearance was more accurate than that by endoscopic biopsy (90% vs 81%). Unlike the positive predictive values, the negative predictive values for malignancy were weak: 33% for the endoscopic appearance and 50% for the endoscopic biopsy.
Because of a high incidence of concurrent cholelithiasis, many patients with a periampullary tumor seen during ERCP are misdiagnosed earlier (by clinical evaluation and non-invasive imaging) as having choledocholithiasis only. However, the accuracy of endoscopy and biopsy is also limited. This limitation must be considered when evaluating the optimal management of patients with suspected periampullary tumor.
对可疑的十二指肠乳头进行内镜检查及活检可在术前早期诊断壶腹周围肿瘤。然而,关于该检查诊断准确性的信息有限且存在差异。本研究的目的是回顾性评估该检查相对于其他诊断方法的准确性。
在928例因内镜逆行胰胆管造影(ERCP)转诊至我院的患者中,发现28例存在可疑的十二指肠乳头。对每例患者,比较了ERCP术前临床诊断、内镜表现、内镜活检的组织学解读及最终诊断。2例无法获得最终诊断的患者被排除在研究之外。
17例患者(65%)最终诊断为壶腹或壶腹周围癌,3例患者(12%)诊断为乳头腺瘤内癌,1例患者诊断为腺瘤,1例患者诊断为转移性胆囊癌。其余4例患者(15%)最终诊断为“假肿瘤”(由于胆总管结石)。21例壶腹或壶腹周围肿瘤患者中有8例(约38%)也有胆结石。在所有26例患者中,ERCP术前(通过临床评估和非侵入性成像)对肿瘤与胆总管结石的诊断准确率仅为65%。其中,内镜表现和内镜活检的诊断准确率分别为77%和85%。对于21例癌症患者,内镜表现的诊断比内镜活检更准确(90%对81%)。与阳性预测值不同,恶性肿瘤的阴性预测值较弱:内镜表现为33%,内镜活检为50%。
由于合并胆结石的发生率较高,许多在ERCP检查中发现壶腹周围肿瘤的患者早期(通过临床评估和非侵入性成像)被误诊为仅患有胆总管结石。然而,内镜检查和活检的准确性也有限。在评估可疑壶腹周围肿瘤患者的最佳治疗方案时,必须考虑到这一局限性。